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1-Introduction
(e.g., SR4 [10] and SprF1 [6•]) [11] . 23 Most type I toxins identified to date have conserved structural features: they generally contain less 24 than 60 amino acids are hydrophobic and have a putative α-helical transmembrane domain, 25 except for SymE and RalR [12,13•] . Despite these similarities, the biological functions and 26 mechanisms of action of type I toxins can be very diverse. Therefore, inspired by Jahn and collaborators [14••] , type I TA systems were cataloged in this review based on the toxins' 28 currently-known mechanisms of action, and are summarized here in Table 1 . Many studies 29 reporting type I toxin functions were based upon episomal overproduction, and deletion of the 30 modules was not often associated with a phenotype. For this reason, it remains difficult to 31 distinguish between the primary and secondary molecular targets of type I toxins.
33
1/ Membrane-associated type I toxins 34 Some membrane-associated type I toxins have been reported to disrupt membrane integrity 35 through pore formation or via nucleoid condensation. However, for many type I toxins, either no, or 36 only one of these mechanisms has been investigated experimentally. a-Peptides inducing membrane permeation through pore-formation 38 Some type I toxins, similar to the phage holin proteins, are membrane-associated peptides that 39 form pores, resulting in a drop in potential and ATP synthesis. Thus, their overexpression leads to 40 cell death, evidenced by the appearance of "ghost" cells with translucent centers and cell material 41 located at the poles. However, in physiological conditions, these pore-forming peptides are 42 involved in diverse biological functions (see the summary in Figure 1 ). 43 The Hok toxic peptide in Escherichia coli, expressed from the hok/sok (or parB) locus of the R1 44 plasmid [1] , is an example of pore-forming peptide. It was the first type I TA system discovered on 45 plasmids that confers their maintenance by PSK [15] . hok/sok homologs were identified in the 46 chromosomes of Gram-negative bacteria, suggesting their involvement in other functions [37, 38] .
In response to nutrient starvation, the stringent response alarmone (p)ppGpp interacts with Obg
48
GTPase, resulting in the induction of the hokB toxin-encoding mRNA through an unknown 49 mechanism [16••] . This moderateoverexpression leads to membrane depolarization responsible 50 for a switch to a persistent state. Persister cells are a bacterial subpopulation that enters into a 51 dormant state and thus becomes tolerant to antibiotics. While the deletion of hokB locus has no 52 effect on persistence, possibly due to system redundancies, the overexpression of hokB mRNA is essential for Obg-mediated persistence. Another recent study [17•] sequences [38] .
60
TisB translated from the "tisB-istR1" locus is another pore-forming peptide. The TisB toxic peptide 61 is small, hydrophobic, and spontaneously binds membranes [39] . Chemically-synthesized TisB 62 peptides are assembled as stable transmembrane dimers. The charges on the amphiphilic TisB 63 helix suggest that antiparallel dimers could be assembled by salt bridges, and these narrow 64 channels could enable protons to pass across the hydrophobic membranes. Another study [20] 65 revealed that the positively-charged TisB pores induce selective membrane permeation for 66 hydroxyl anions. In turn, protons and anions passages dissipate the proton motive force (PMF).
67
The TisB pore is so narrow that it is impermeable to intracellular water-soluble components, 68 allowing cell survival. As a consequence, tisB mRNA overexpression causes a drop in ATP levels 69 and an increase of cell death even though in physiological conditions it induces a drop in the PMF 70 and the formation of persister cells [20] . By triggering a dormant state, TisB leads to the shutdown 71 of the major antibiotic targets and induces multidrug tolerance (e.g., in β-lactams targeting 72 peptidoglycan synthesis, in aminoglycosides inhibiting translation, and in ciprofloxacin reducing
73
DNA replication by inhibiting topoisomerase activity). This phenotype has only been observed in 74 exponentially-growing E. coli cells, corresponding to a higher expression of the genes involved in 75 the SOS response [19] . Persister formation by the SOS-induced TisB toxin involves two strategies 76 for survival: DNA repair activation; and entrance into a dormant state [19] . 
b-Peptides inducing nucleoid condensation
The par locus, or the RNAI-RNAII TA system (see Figure 2) , is expressed from the pAD1 plasmid 80 of Enterococcus faecalis and encodes the Fst toxin. The par homologs have been detected in low 81 GC Gram-positive bacteria [22] . The Fst toxic peptide possesses a hydrophobic transmembrane 82 domain that is essential for toxicity and conserved within the Fst/Ldr superfamily. This is followed
83
by an unstructured C-terminal tail, probably located in the cytoplasm [22] daughter cells [23, 40] . While the early effects of fst toxin-encoding mRNA overexpression are at 89 the chromosomal level, its major impact is the membrane stress that induces the transcription of 90 numerous target genes [23] . The majority of these targeted transcripts encode membrane- [42] . RNAI-RNAII is the only type I PSK system described so far in Gram-positive bacteria [23] , 99 although numerous par homologs have been detected in many bacterial chromosomes [22] .
100
Interestingly, overexpression of the fst-Sm/srSm TA system in Streptococcus mutans causes a 101 significant decrease in the number of persister cells [34] . Moreover, in the opportunistic pathogen In E. coli, overproduction of the LdrD protein, which belongs to the Fst/Ldr superfamily [4] , leads to 108 nucleoid condensation [25] , suggesting a conserved mechanism of action. Additionally, microarray 109 analysis suggests that overexpression of ldrD mRNA upregulates genes involved in the purine 110 metabolism pathway, and reduces cAMP levels [25] . Interestingly, overexpression of the ldrD 111 mRNA homolog ldrA inhibits ATP synthesis and consequently DNA replication, transcription, and 112 translation, eventually inducing cell growth arrest [44] .
113
The E. coli DinQ toxic peptide is a small transmembrane peptide located in the inner membrane.
114
Its expression is controlled by AgrB antisense RNA and the repressor LexA which downregulates 115 numerous genes involved in the SOS response [45] . Ectopic overexpression of dinQ mRNA 116 induces membrane depolarization [21] . In an agrB mutant strain, two-fold constitutive 117 overexpression of dinQ mRNA leads to an increase in UV sensitivity associated with a decrease in 118 intracellular ATP and a delay in nucleoid decompaction and extension after UV irradiation.
119
Moreover, elevated levels of dinQ mRNA in this mutant have a role in the repair of UV-induced 120 DNA damage through inhibition of conjugal recombination [21] . Thus, the DinQ toxin uses several 121 mechanisms to modulate the E. coli UV response. There are many other membrane-associated type I toxins with the mechanism of action still to be 137 determined (see Table 1 ). For many systems, the mechanism was not addressed. For the others, 138 information to classify toxins according to their mechanisms of action is insufficient.
139
Among them, in the human pathogen S. aureus, two type I TA systems are located within a 140 pathogenicity island (PI) and express membrane toxic peptides whose overexpression causes 141 bacterial cell death. PepA1, translated from the "sprA1/sprA1 AS " locus, is induced upon acidic and 142 oxidative stresses [46] . PepG1 31 and PepG1 44 are both translated from the "sprG1/sprF1" locus.
143
Extracellular addition of either the three chemically-synthesized peptides or of membrane extracts 144 prepared from S. aureus cells overexpressing PepG1 44 and PepG1 31 will trigger the lysis of both 145 competing bacteria and human erythrocytes [6•,7] . NMR structures and dynamic simulations 146 indicate that synthetic PepA1 possesses an α-helical structure and can insert into the membrane.
147
These toxic peptides probably damage bacterial membranes and erythrocytes through pore-148 formation, membrane disruption due to a detergent-like effect, or by interference with membrane-149 associated functions, nevertheless we cannot exclude a role of these toxins in nucleoid 150 condensation [46] . 
a-RNA cleavage
SymE is a 113-amino acid peptide that, like the MazE type II antitoxin, contains an AbrB [47] . SymR antitoxin RNA and at the translational level by SymR and Lon proteases [12] . In E. coli, the 164 SymE protein co-purifies with ribosomal proteins, and its overexpression drastically affects colony-165 forming ability and protein synthesis [12] . Overexpression of symE mRNA decreases levels of all 166 tested mRNAs and regulatory RNAs except its antitoxin SymR. Moreover, after symE mRNA 167 induction, distinct shorter mRNA fragments were observed. These results suggest that SymE acts 168 as an endoribonuclease and cleaves mRNAs that should not be translated [12, 48] . The DNA RalR toxin is a non-specific endonuclease that cleaves methylated or non-methylated DNAs. 
2-Concluding remarks and perspectives
When examined together, the effects of some type I toxins on bacterial physiology challenge the 187 concept that membrane-associated type I toxins act solely by pore formation. This is why we 
208
The unique characteristics of TA loci make them of particular interest for biotechnological 209 applications. TAs can be considered lead compounds for the design of new antimicrobials, 210 plasmid maintenance tools, vaccines, and selective reporter genes [51, 52] . Moreover, toxins on 211 their own can also have various applications. Indeed, selective cloning vectors containing variants of IbsC, a type I E. coli toxic peptide, have been engineered [53] . In addition, chemical 213 modifications of PepA1 toxin dramatically increased its antibacterial potential and its stability in 214 human serum while considerably reducing its human cell toxicity, implying that toxins can be 215 transformed into potent antibiotics [27] . The DinQ toxin is another promising candidate for the 216 development of anti-cell-envelope antibiotics, notably against E. coli infection [54] . These 217 strategies could be applied to other toxic peptides, notably for the design of new antibiotics, thus 218 providing alternatives to the burgeoning issue of bacterial resistance to the drugs presently in use. death [23] , [42] . 1 TA systems expressed in other bacteria and/or in other copies located in the bacterial genome. 2 Plasmid maintenance identified using plasmid other than the plasmid of origin expressing the TA locus. 3 Biological functions identified when the TA systems are highly expressed using overexpression plasmids with endogenous or inducible promoters. 4 In vitro analysis with chemically synthesized peptides. 5 The environmental conditions induce a modulation of the toxin mRNA expression in the wild-type strain. 
